Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125773161 | 12577316 | 1 | I | 20160409 | 20160706 | 20160720 | 20160720 | EXP | RE20160637 | FR-VALIDUS PHARMACEUTICALS LLC-FR-2016VAL002285 | VALIDUS | 68.00 | YR | F | Y | 0.00000 | 20160720 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125773161 | 12577316 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, DAILY | Y | 16273 | 40 | MG | TABLET | ||||||
| 125773161 | 12577316 | 2 | SS | PERINDOPRIL | PERINDOPRIL | 1 | Oral | 1 DF, DAILY | Y | 0 | 1 | DF | |||||||
| 125773161 | 12577316 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Oral | 3 DF, DAILY | Y | 0 | 3 | DF | FILM-COATED TABLET | ||||||
| 125773161 | 12577316 | 4 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 2 DF, DAILY | Y | 0 | 2 | DF | CAPSULE | ||||||
| 125773161 | 12577316 | 5 | SS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | UNK | Y | 0 | CAPSULE | ||||||||
| 125773161 | 12577316 | 6 | C | FLECAINE | FLECAINIDE | 1 | UNK | 0 | |||||||||||
| 125773161 | 12577316 | 7 | C | ATORVASTATIN | ATORVASTATIN | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 125773161 | 12577316 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 125773161 | 12577316 | 9 | C | COLCHICINE. | COLCHICINE | 1 | UNK | U | 0 | ||||||||||
| 125773161 | 12577316 | 10 | C | VESICARE | SOLIFENACIN SUCCINATE | 1 | 6 MG, UNK | 0 | 6 | MG | |||||||||
| 125773161 | 12577316 | 11 | C | NEBIVOLOL. | NEBIVOLOL | 1 | 5 MG, UNK | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125773161 | 12577316 | 1 | Hypertension |
| 125773161 | 12577316 | 2 | Hypertension |
| 125773161 | 12577316 | 3 | Back pain |
| 125773161 | 12577316 | 4 | Product used for unknown indication |
| 125773161 | 12577316 | 6 | Atrial fibrillation |
| 125773161 | 12577316 | 7 | Dyslipidaemia |
| 125773161 | 12577316 | 8 | Product used for unknown indication |
| 125773161 | 12577316 | 9 | Product used for unknown indication |
| 125773161 | 12577316 | 10 | Urinary incontinence |
| 125773161 | 12577316 | 11 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125773161 | 12577316 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125773161 | 12577316 | Acute kidney injury | |
| 125773161 | 12577316 | Coagulopathy | |
| 125773161 | 12577316 | Dizziness | |
| 125773161 | 12577316 | Malaise | |
| 125773161 | 12577316 | Muscular weakness | |
| 125773161 | 12577316 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125773161 | 12577316 | 1 | 201605 | 0 | ||
| 125773161 | 12577316 | 2 | 201605 | 0 | ||
| 125773161 | 12577316 | 3 | 201605 | 0 | ||
| 125773161 | 12577316 | 4 | 201605 | 0 | ||
| 125773161 | 12577316 | 9 | 201602 | 0 |